Literature DB >> 7610488

Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging.

G S Roth1, J A Joseph, R P Mason.   

Abstract

Changes in cell-membrane composition in normal aging and in Alzheimer's and other age-related diseases appear to result in impaired neurotransmitter-triggered signal transduction. The impaired signal transduction seems to be related to dysfunctions in the coupling of G proteins to their receptors and effectors. Direct demonstration of altered physiochemical properties of brain tissue of patients with Alzheimer's disease has been achieved by small-angle X-ray diffraction. In this disease, thinner membranes correlate with a 30% decrease in moles of cholesterol:phospholipid. Such changes can affect directly the coupling and uncoupling properties of G proteins, and can account for signal transduction deficits. These findings offer a complementary alternative to the beta-amyloid hypothesis, and an opportunity to consider new types of therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7610488     DOI: 10.1016/0166-2236(95)93902-a

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  22 in total

1.  Decreased G-protein-mediated regulation and shift in calcium channel types with age in hippocampal cultures.

Authors:  E M Blalock; N M Porter; P W Landfield
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

Review 2.  Amyloid beta peptide membrane perturbation is the basis for its biological effects.

Authors:  J N Kanfer; G Sorrentino; D S Sitar
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

Review 3.  Neuronutrition and Alzheimer's disease.

Authors:  Balenahalli N Ramesh; T S Sathyanarayana Rao; Annamalai Prakasam; Kumar Sambamurti; K S Jagannatha Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons.

Authors:  J F Kelly; K Furukawa; S W Barger; M R Rengen; R J Mark; E M Blanc; G S Roth; M P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

5.  Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.

Authors:  J J Claus; E A Dubois; J Booij; J Habraken; J C de Munck; M van Herk; B Verbeeten; E A van Royen
Journal:  Eur J Nucl Med       Date:  1997-06

6.  Age-dependent organotypic expression of microtubule-associated proteins (MAP1, MAP2, and MAP5) in rat brain.

Authors:  N Chauhan; G Siegel
Journal:  Neurochem Res       Date:  1997-06       Impact factor: 3.996

7.  Differential effect of CDP-choline on brain cytosolic choline levels in younger and older subjects as measured by proton magnetic resonance spectroscopy.

Authors:  S M Babb; K E Appelmans; P F Renshaw; R J Wurtman; B M Cohen
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

8.  Expression of fatty acid binding proteins is altered in aged mouse brain.

Authors:  L Pu; U Igbavboa; W G Wood; J B Roths; A B Kier; F Spener; F Schroeder
Journal:  Mol Cell Biochem       Date:  1999-08       Impact factor: 3.396

9.  In vitro sensitivity of cholinesterases and [3H]oxotremorine-M binding in heart and brain of adult and aging rats to organophosphorus anticholinesterases.

Authors:  Nikita Mirajkar; Carey N Pope
Journal:  Biochem Pharmacol       Date:  2008-08-12       Impact factor: 5.858

10.  Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with Abeta(1-40) peptide in a membrane mimic environment.

Authors:  Pravat K Mandal; Jay W Pettegrew
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.